637 related articles for article (PubMed ID: 31683658)
1. Laquinimod Supports Remyelination in Non-Supportive Environments.
Nyamoya S; Steinle J; Chrzanowski U; Kaye J; Schmitz C; Beyer C; Kipp M
Cells; 2019 Oct; 8(11):. PubMed ID: 31683658
[TBL] [Abstract][Full Text] [Related]
2. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
[TBL] [Abstract][Full Text] [Related]
3. A new model of cuprizone-mediated demyelination/remyelination.
Sachs HH; Bercury KK; Popescu DC; Narayanan SP; Macklin WB
ASN Neuro; 2014; 6(5):. PubMed ID: 25290063
[TBL] [Abstract][Full Text] [Related]
4. p38γ MAPK delays myelination and remyelination and is abundant in multiple sclerosis lesions.
Marziali LN; Hwang Y; Palmisano M; Cuenda A; Sim FJ; Gonzalez A; Volsko C; Dutta R; Trapp BD; Wrabetz L; Feltri ML
Brain; 2024 May; 147(5):1871-1886. PubMed ID: 38128553
[TBL] [Abstract][Full Text] [Related]
5. Deciphering the Genetic Crosstalk between Microglia and Oligodendrocyte Precursor Cells during Demyelination and Remyelination Using Transcriptomic Data.
Enrich-Bengoa J; Manich G; Dégano IR; Perálvarez-Marín A
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499195
[TBL] [Abstract][Full Text] [Related]
6. G-Protein-Coupled Receptor Gpr17 Expression in Two Multiple Sclerosis Remyelination Models.
Nyamoya S; Leopold P; Becker B; Beyer C; Hustadt F; Schmitz C; Michel A; Kipp M
Mol Neurobiol; 2019 Feb; 56(2):1109-1123. PubMed ID: 29873041
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis risk gene Mertk is required for microglial activation and subsequent remyelination.
Shen K; Reichelt M; Kyauk RV; Ngu H; Shen YA; Foreman O; Modrusan Z; Friedman BA; Sheng M; Yuen TJ
Cell Rep; 2021 Mar; 34(10):108835. PubMed ID: 33691116
[TBL] [Abstract][Full Text] [Related]
8. Cuprizone effect on myelination, astrogliosis and microglia attraction in the mouse basal ganglia.
Pott F; Gingele S; Clarner T; Dang J; Baumgartner W; Beyer C; Kipp M
Brain Res; 2009 Dec; 1305():137-49. PubMed ID: 19799876
[TBL] [Abstract][Full Text] [Related]
9. Quantitative temporal changes in DTI values coupled with histological properties in cuprizone-induced demyelination and remyelination.
Yano R; Hata J; Abe Y; Seki F; Yoshida K; Komaki Y; Okano H; Tanaka KF
Neurochem Int; 2018 Oct; 119():151-158. PubMed ID: 29030079
[TBL] [Abstract][Full Text] [Related]
10. Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination.
Schultz V; van der Meer F; Wrzos C; Scheidt U; Bahn E; Stadelmann C; Brück W; Junker A
Glia; 2017 Aug; 65(8):1350-1360. PubMed ID: 28560740
[TBL] [Abstract][Full Text] [Related]
11. Targeting TrkB with a Brain-Derived Neurotrophic Factor Mimetic Promotes Myelin Repair in the Brain.
Fletcher JL; Wood RJ; Nguyen J; Norman EML; Jun CMK; Prawdiuk AR; Biemond M; Nguyen HTH; Northfield SE; Hughes RA; Gonsalvez DG; Xiao J; Murray SS
J Neurosci; 2018 Aug; 38(32):7088-7099. PubMed ID: 29976621
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of Protein Tyrosine Phosphatase Receptor Type Z by Pleiotrophin Promotes Remyelination through Activation of Differentiation of Oligodendrocyte Precursor Cells.
Kuboyama K; Fujikawa A; Suzuki R; Noda M
J Neurosci; 2015 Sep; 35(35):12162-71. PubMed ID: 26338327
[TBL] [Abstract][Full Text] [Related]
13. Butyrate suppresses demyelination and enhances remyelination.
Chen T; Noto D; Hoshino Y; Mizuno M; Miyake S
J Neuroinflammation; 2019 Aug; 16(1):165. PubMed ID: 31399117
[TBL] [Abstract][Full Text] [Related]
14. Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination.
Butti E; Bacigaluppi M; Chaabane L; Ruffini F; Brambilla E; Berera G; Montonati C; Quattrini A; Martino G
J Neurosci; 2019 Jul; 39(28):5481-5492. PubMed ID: 31138656
[TBL] [Abstract][Full Text] [Related]
15. The antibody rHIgM22 facilitates hippocampal remyelination and ameliorates memory deficits in the cuprizone mouse model of demyelination.
Cui C; Wang J; Mullin AP; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
Brain Res; 2018 Sep; 1694():73-86. PubMed ID: 29775564
[TBL] [Abstract][Full Text] [Related]
16. Regulatory effect of triiodothyronine on brain myelination and astrogliosis after cuprizone-induced demyelination in mice.
Zendedel A; Kashani IR; Azimzadeh M; Pasbakhsh P; Omidi N; Golestani A; Beyer C; Clarner T
Metab Brain Dis; 2016 Apr; 31(2):425-33. PubMed ID: 26725831
[TBL] [Abstract][Full Text] [Related]
17. Laquinimod ameliorates secondary brain inflammation.
Nedelcu J; Reinbach C; Riedler P; Brendel M; Rominger A; Kaye J; Behrangi N; Jiangshan Z; Schmitz C; Kipp M
Neurobiol Dis; 2020 Feb; 134():104675. PubMed ID: 31731041
[TBL] [Abstract][Full Text] [Related]
18. Evaluation strategy to determine reliable demyelination in the cuprizone model.
Chrzanowski U; Schmitz C; Horn-Bochtler A; Nack A; Kipp M
Metab Brain Dis; 2019 Apr; 34(2):681-685. PubMed ID: 30607821
[TBL] [Abstract][Full Text] [Related]
19. Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination.
Lindner M; Fokuhl J; Linsmeier F; Trebst C; Stangel M
Neurosci Lett; 2009 Apr; 453(2):120-5. PubMed ID: 19356606
[TBL] [Abstract][Full Text] [Related]
20. How to Use the Cuprizone Model to Study De- and Remyelination.
Kipp M
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
